Dupuytrens contracture

Jump to navigation Jump to search
Dupuytren's contracture
Dupuytren's contracture of the fourth digit (ring finger).
ICD-10 M72.0
ICD-9 728.6
OMIM 126900
DiseasesDB 4011
MedlinePlus 001233

WikiDoc Resources for Dupuytrens contracture

Articles

Most recent articles on Dupuytrens contracture

Most cited articles on Dupuytrens contracture

Review articles on Dupuytrens contracture

Articles on Dupuytrens contracture in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dupuytrens contracture

Images of Dupuytrens contracture

Photos of Dupuytrens contracture

Podcasts & MP3s on Dupuytrens contracture

Videos on Dupuytrens contracture

Evidence Based Medicine

Cochrane Collaboration on Dupuytrens contracture

Bandolier on Dupuytrens contracture

TRIP on Dupuytrens contracture

Clinical Trials

Ongoing Trials on Dupuytrens contracture at Clinical Trials.gov

Trial results on Dupuytrens contracture

Clinical Trials on Dupuytrens contracture at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dupuytrens contracture

NICE Guidance on Dupuytrens contracture

NHS PRODIGY Guidance

FDA on Dupuytrens contracture

CDC on Dupuytrens contracture

Books

Books on Dupuytrens contracture

News

Dupuytrens contracture in the news

Be alerted to news on Dupuytrens contracture

News trends on Dupuytrens contracture

Commentary

Blogs on Dupuytrens contracture

Definitions

Definitions of Dupuytrens contracture

Patient Resources / Community

Patient resources on Dupuytrens contracture

Discussion groups on Dupuytrens contracture

Patient Handouts on Dupuytrens contracture

Directions to Hospitals Treating Dupuytrens contracture

Risk calculators and risk factors for Dupuytrens contracture

Healthcare Provider Resources

Symptoms of Dupuytrens contracture

Causes & Risk Factors for Dupuytrens contracture

Diagnostic studies for Dupuytrens contracture

Treatment of Dupuytrens contracture

Continuing Medical Education (CME)

CME Programs on Dupuytrens contracture

International

Dupuytrens contracture en Espanol

Dupuytrens contracture en Francais

Business

Dupuytrens contracture in the Marketplace

Patents on Dupuytrens contracture

Experimental / Informatics

List of terms related to Dupuytrens contracture

Editors-In-Chief: Matthew I. Leibman, M.D.[1]; Mark R. Belsky, M.D.[2]; David E. Ruchelsman, M.D.[3]Kiran Singh, M.D. [4]

Synonyms and keywords: Dupuytren contracture I, included; DUPC1; palmar fascial fibromatosis; palmar fibromatosis

Overview

Dupuytren's contracture (also known as Morbus Dupuytren) is a fixed flexion contracture of the hand where the fingers bend towards the palm and cannot be fully extended (straightened). It is named after the famous surgeon Baron Guillaume Dupuytren, who described an operation to correct the affliction.

The ring finger and little finger are the fingers most commonly affected; the middle finger may be affected in advanced cases, but index finger and thumb are nearly always spared. Dupuytren's contracture progresses slowly and is usually painless. In patients with this condition, the tissues under the skin on the palm of the hand thicken and shorten so that the tendons connected to the fingers cannot move freely. The palmar aponeurosis becomes hyperplastic and undergoes contracture. As a result, the affected fingers start to bend more and more and cannot be straightened.

Incidence increases after the age of 40; at this age men are affected more often than women. After the age of 80 the distribution is about even.

Historical Perspective

Pathophysiology

Pathogenesis

Associated Conditions


Causes

The cause of Dupuytren's contracture has not been identified.

Symptoms

In Dupuytren's disease, the tough connective tissue within one's hand becomes abnormally thick, which can cause the fingers to curl, and can result in impaired function of the fingers, especially the small and ring fingers. It usually has a gradual onset, often beginning as a tender lump in the palm. Over time, pain associated with the condition tends to go away, but tough bands of tissue may develop. These bands, which are the source of the reduced mobility commonly associated with the condition, are visible on the surface of the palm, and may appear similar to a small callus. It commonly develops in both hands, and has no connection to dominant- or non-dominant hands, nor any correlation with right- or left-handedness.

The contracture sets on very slowly, especially in women. However, when present in both hands, and when there is associated foot involvement, it tends to accelerate more rapidly.

Epidemiology and Demographics

Prevalence

Age

Race

  • Dupuytren's contracture usually affects individuals of the northern Europeans race (Icelandic and Scandinavian populations).

Gender

  • Males are more commonly affected by Dupuytren's contracture than females. The male to female ratio is approximately 3 to 1.


Risk Factors

Common risk factors in the development of Dupuytren's contracture include:

Natural History, Complications and Prognosis

Natural History

Prognosis

Diagnosis

Diagnostic Study of Choice

Dupuytren’s disease is primarily diagnosed based on the clinical presentation.

History and Symptoms


Physical Examination

Skin

Hand

Treatment

  • Surgery (in cases of severe contracture removes the contracture)
  • Radiation therapy (specifically in early stages inhibits development of contracture)
  • Needle aponeurotomy (releases the contracture)
  • Triamcinolone (kenalog) injections provide some relief

Surgical management consists of opening the skin over the affected cords and excising, removing, the fibrous tissue. The fingers may then be brought out to length with the help of postoperative therapy. The procedure is not curative in that remaining non-affected fascia may still develop Dupuytren's disease later on, and therefore the patients may need repeat surgery. In addition, the thickened fascia often invests the digital nerves and arteries, so there is some risk of nerve and/or arterial injury.

Treatment of Dupuytren's disease with low energy x-rays (radiotherapy) may cure Morbus Dupuytren on a long term, specifically if applied in early stages of the disease. Needle aponevrotomy is a minimal invasive technique where the cords are weakened through the insertion and manipulation of a small needle. Once weakened, the offending cords may be snapped by simply pulling the finger(s) straight. The nodules are not removed and might start growing again. Currently in phase III of Food and Drug Administration (FDA) approval is another promising therapy, the injection of collagenase. This procedure is similar to needle aponevrotomy, however the chords are weakened through the injection of small amounts of an enzyme that dissolves them.

Dupuytren's contracture is not a dangerous condition, and often no treatment is necessary. Even when treatment is used, there is no permanent way to stop or cure the infliction. If there is a painful lump present, an injection can often help alleviate the pain. If pain persists or the function of the hand becomes seriously impaired, individuals often choose to have surgery. This surgery usually entails removing or separating the thickened bands, and is unlikely to cause any major complications or side effects, although in serious cases, some minor skin grafting may be necessary. Any damaged skin or tissue in the surgically affected area of the hand will heal fairly quickly, and reducing bloodflow during the healing period helps reduce pain. This may be done by keeping the hand raised or elevated so that blood does not pool in the affected area.

After surgical treatment, the condition may worsen in inadequately excised diseased tissue or re-develop in previously normal tissue.

External links

http://www.nlm.nih.gov/medlineplus/ency/article/001233.htm

Template:Diseases of the musculoskeletal system and connective tissue


de:Morbus Dupuytren it:Malattia di Dupuytren nl:Ziekte van Dupuytren


Template:WikiDoc Sources

  1. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1136/bmj.n1308 Check |pmid= value (help).
  2. Gudmundsson KG, Arngrimsson R, Jónsson T (2001). "Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease". Scand J Rheumatol. 30 (1): 31–4. doi:10.1080/030097401750065292. PMID 11252689.
  3. 3.0 3.1 3.2 "Dermatology Atlas".